Tarsus Pharmaceuticals, Inc.
TARS· Nasdaq
Released Nov 24, 2020, after the close
10-Q filed Nov 25, 2020, 56 days after period end · 0001819790-20-000005
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2020 | Q3 2019 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$10.14M | -$681.00K |
| EPS Diluted | -$3.71 | -$0.28 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tarsus Pharmaceuticals, Inc. · CIK 1819790 · Engraved from SEC EDGAR
ended Sep 30, 2020 · filed Nov 25, 2020 · 56 d after period end
4.4% from the close of Nov 24, 2020 to the close of Nov 25, 2020, the first after the release.